Ablative therapy with UGN-102 for low-grade intermediate risk non-muscle-invasive bladder cancer: ready for primetime?

ABSTRACT:

SUBMITTER: Lichtbroun B 

PROVIDER: S-EPMC11074688 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature